Northacre PLC
28 April 2000
NORTHACRE
Acquisition of Queen Elizabeth College
Northacre PLC announce the signing of a Joint Venture with Westcity
Group and completion of the acquisition of the freehold of Queen
Elizabeth College on Campden Hill Road, W8. This is an imposing
Grade II listed building, formerly part of Kings College London and
opposite one of Northacre's previous schemes at Observatory Gardens.
The transaction will involve working closely with Kings College and
their PFI partners, European Land, to secure planning permission with
the aim of creating a development of 200,000 sq ft in the style of
Northacre's highly acclaimed scheme at The Bromptons, SW3 and
Westcity's at the Pavillions, NW8.
Northacre, together with Westcity, have invested £18m of equity to
secure a loan for the acquisition and the subsequent residential
development of the Campden Hill site. This transaction will
significantly compliment Northacre's Central London development
programme at The Bromptons and Earls Terrace in addition to their
development management and profit share participation at KINGS
Chelsea.
Enquiries:
Northacre PLC
John Hunter, Chief Executive Tel: 0207 349 8000
College Hill Tel: 0207 457 2020
Kate Pope
Matthew Smallwood
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.